In a huge victory for pharmaceutical giant Wyeth, a Florida appeals court on Wednesday halted a class action suit that claimed its hormone replacement drug could harm hundreds of thousands of Florida women.

A three-judge panel of the state’s 3rd District Court of Appeal unanimously held in Wyeth Inc. v. Arlene Gottlieb that the claims were not common enough for the case to move forward as a class action. Instead, women who claim they may suffer future health problems because of their use of the drug Prempro will have to file individual suits against Wyeth.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]